This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Resources - Articles

The Power Of Clinical Trial Supply Visibility

Over the last few years the number of innovative drugs brought to market has declined as pharmaceutical companies have focussed their resources on improvements to existing drugs or expanding their off-label use.

In part, the evolution of this trend can be traced to the advent of corporate mergers between pharmaceutical companies which has left much of the innovation gap in new medications to be filled by biopharma. Indeed, it is from these relatively small companies that the majority of new products and innovations have emerged in recent years…

Read more about this here

October 12, 2015


Expansion of High Potent Tableting and Powder Modification Capacity

Investment in new technologies at PCI’s global manufacturing Center of Excellence in Tredegar, Wales, to double highly potent tableting capacity... View Article

PCI Welcomes New Chief Financial Officer and SVP, Serge Dupuis

PCI is pleased to welcome Serge Dupuis as Senior Vice President and Chief Financial Officer. Serge’s appointment supports PCI’s continued... View Article

x